Dr. André Abts

Vice President Project Managment CMC
ProtaGene, Germany
André Abts, PhD, is the Vice President of Project Management CMC at ProtaGene. He is a CMC expert with over eight years of experience leading the implementation, optimization, and harmonization of project management processes across the organization. Dr. Abts manages NBE and biosimilar projects of different stages, from early development to Phase III and market approval under GMP. He also plays a key role in collaborating with international pharmaceutical clients and authoring regulatory documentation for health authorities. Dr. Abts joined Protagen Protein Services GmbH in 2014, where he served as a Project Manager of Biotherapeutics and later as the Head of Project Management of Biologics. Dr. Abts holds a PhD in Biochemistry and a Diplom in Chemistry from Heinrich-Heine-University Düsseldorf, where he engaged in protein and peptide research in the field of antibiotics and antimicrobial peptides at the Institute for Biochemistry.

Events/Masterclasses Dr. André Abts is currently speaking at

Pharma

CMC Analytical Comparability: Methods & Strategies for Biologics
24 - 25 November 2022
Vienna, Austria | Online Live Stream 09:00 CET - 17:30 CET
Join our CMC Analytical Comparability training led by experts to understand principles of protein structure and comparative analytics.

Are you interested in a custom-made event with this trainer?

Contact us to Request more information about your custom-made Corporate Learning program.

REQUEST MORE INFORMATION

Dr. André Abts
Vice President Project Managment CMC
ProtaGene, Germany
André Abts, PhD, is the Vice President of Project Management CMC at ProtaGene. He is a CMC expert with over eight years of experience leading the implementation, optimization, and harmonization of project management processes across the organization. Dr. Abts manages NBE and biosimilar projects of different stages, from early development to Phase III and market approval under GMP. He also plays a key role in collaborating with international pharmaceutical clients and authoring regulatory documentation for health authorities. Dr. Abts joined Protagen Protein Services GmbH in 2014, where he served as a Project Manager of Biotherapeutics and later as the Head of Project Management of Biologics. Dr. Abts holds a PhD in Biochemistry and a Diplom in Chemistry from Heinrich-Heine-University Düsseldorf, where he engaged in protein and peptide research in the field of antibiotics and antimicrobial peptides at the Institute for Biochemistry.
Dr. André Abts
Description